| GTO ID | GTC1144 |
| Trial ID | NCT00002221 |
| Disease | T-Cell Non-Hodgkin's Lymphoma |
| Altered gene | ribozyme |
| Therapeutic/Target gene | Target gene |
| Therapy | Gene transfer |
| Treatment | ribozyme-modified CD34+ cells |
| Phase | Phase2 |
| Recruitment status | Completed |
| Title | High Dose Chemotherapy and Autologous Peripheral Stem Cell Transplantation for HIV Lymphomas: A Phase IIA Study of Comparative Marking Using a Ribozyme Gene and a Neutral Gene |
| Year | 1999 |
| Country | United States |
| Company sponsor | Pegaptanib Sodium Multi-center Study Group |
| Other ID(s) | STUDY 2 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||
|
|||||||